This inventor holds 1 USPTO granted patent. Top assignee: Serum Institute of India Private Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Shashikant Janardan Ghodekar: Innovator in Vaccine Development
Introduction
Shashikant Janardan Ghodekar is a prominent inventor based in Pune, Maharashtra, India. He has made significant contributions to the field of vaccine development, particularly in creating stable vaccine compositions. His work is crucial in advancing immunogenic compositions that are both effective and safe for use.
Latest Patents
Shashikant holds a patent for "Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof." This innovative patent describes stable lyophilized immunogenic compositions that include live attenuated recombinant flaviviruses, specifically targeting dengue viruses. The composition is designed to preserve the virus's viability, immunogenicity, and stability while being devoid of preservatives, polymers, and surfactants. The methods for manufacturing these stable compositions are also outlined in the patent.
Career Highlights
Shashikant is associated with the Serum Institute of India Private Limited, a leading organization in vaccine production. His work at the institute has been instrumental in developing vaccines that meet global health standards. With a focus on innovation, he continues to contribute to the advancement of immunology and vaccine technology.
Collaborations
Shashikant has collaborated with notable colleagues such as Rajeev Mhalasakant Dhere and Leena Ravindra Yeolekar. These collaborations have fostered a productive environment for research and development in vaccine technology.
Conclusion
Shashikant Janardan Ghodekar is a key figure in the field of vaccine innovation, with a focus on creating stable and effective immunogenic compositions. His contributions are vital for the ongoing efforts in public health and disease prevention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile